rs281865088
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000195.5(HPS1):c.1744-2A>C variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000162 in 1,605,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000195.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPS1 | NM_000195.5 | c.1744-2A>C | splice_acceptor_variant, intron_variant | Intron 17 of 19 | ENST00000361490.9 | NP_000186.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS1 | ENST00000361490.9 | c.1744-2A>C | splice_acceptor_variant, intron_variant | Intron 17 of 19 | 1 | NM_000195.5 | ENSP00000355310.4 | |||
ENSG00000289758 | ENST00000699159.1 | n.*1103-2A>C | splice_acceptor_variant, intron_variant | Intron 16 of 23 | ENSP00000514167.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249556Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135040
GnomAD4 exome AF: 0.0000172 AC: 25AN: 1453510Hom.: 0 Cov.: 27 AF XY: 0.0000138 AC XY: 10AN XY: 723532
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74310
ClinVar
Submissions by phenotype
Hermansky-Pudlak syndrome 1 Pathogenic:2
- -
- -
Hermansky-Pudlak syndrome Pathogenic:1
- -
not provided Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 21097). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Disruption of this splice site has been observed in individual(s) with Hermansky-Pudlak syndrome (PMID: 29941477). This variant is present in population databases (rs281865088, gnomAD 0.003%). This sequence change affects an acceptor splice site in intron 17 of the HPS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in HPS1 are known to be pathogenic (PMID: 12442288, 16185271). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at